Inozyme Pharma Inc.

1.41
-0.11 (-7.24%)
At close: Jan 29, 2025, 3:59 PM
1.42
0.71%
After-hours Jan 29, 2025, 07:55 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY01
Net Income -71.17M -67.06M -56.62M -56.42M -19.72M -6.96M n/a
Depreciation & Amortization 833.00K 744.00K 674.00K 217.00K 83.00K 26.00K n/a
Stock-Based Compensation 7.04M 7.67M 7.16M 2.31M 301.00K 444.00K n/a
Other Working Capital -1.70M 1.86M 760.00K -2.21M 684.00K 629.00K n/a
Other Non-Cash Items -4.29M -1.13M 378.00K 18.04M -71.00K -4.37M n/a
Deferred Income Tax n/a n/a 170.00K n/a n/a n/a n/a
Change in Working Capital -3.08M 2.01M 85.00K -111.00K 601.00K 1.43M n/a
Operating Cash Flow -70.67M -57.76M -48.15M -35.97M -18.81M -9.44M n/a
Capital Expenditures -298.00K -410.00K -397.00K -568.00K -139.00K -259.00K n/a
Acquisitions n/a 4.99K -43.19K 116.61K 8.25K n/a n/a
Purchase of Investments -269.33M -151.99M -121.97M -177.92M -24.66M -13.57M n/a
Sales Maturities Of Investments 215.98M 147.00M 165.16M 61.31M 16.41M 22.83M n/a
Other Investing Acitivies n/a -4.99K 43.19K -116.61K -8.25K 9.27M n/a
Investing Cash Flow -53.65M -5.40M 42.80M -117.18M -8.39M 9.01M n/a
Debt Repayment 40.00M 4.05M n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 322.00K 12.60M 609.00K 33.84M 22.97M 31.95M n/a
Financial Cash Flow 125.97M 72.79M 609.00K 149.81M 22.97M 31.95M n/a
Net Cash Flow 1.63M 9.60M -4.72M -3.34M -4.23M 31.51M n/a
Free Cash Flow -70.97M -58.17M -48.55M -36.54M -18.95M -9.70M n/a

Create Price Alert on INZY

Your price alert will notify you when the stock price is above 1.41.

Add to Watchlist